ID   A0A1I7SXM5_9PELO        Unreviewed;       592 AA.
AC   A0A1I7SXM5;
DT   18-JAN-2017, integrated into UniProtKB/TrEMBL.
DT   18-JAN-2017, sequence version 1.
DT   22-FEB-2023, entry version 17.
DE   SubName: Full=NRF domain-containing protein {ECO:0000313|WBParaSite:Csp11.Scaffold17.g76.t1};
OS   Caenorhabditis tropicalis.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=1561998 {ECO:0000313|Proteomes:UP000095282, ECO:0000313|WBParaSite:Csp11.Scaffold17.g76.t1};
RN   [1] {ECO:0000313|WBParaSite:Csp11.Scaffold17.g76.t1}
RP   IDENTIFICATION.
RG   WormBaseParasite;
RL   Submitted (NOV-2016) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; A0A1I7SXM5; -.
DR   WBParaSite; Csp11.Scaffold17.g76.t1; Csp11.Scaffold17.g76.t1; Csp11.Scaffold17.g76.
DR   eggNOG; KOG3700; Eukaryota.
DR   Proteomes; UP000095282; Unplaced.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016747; F:acyltransferase activity, transferring groups other than amino-acyl groups; IEA:InterPro.
DR   InterPro; IPR002656; Acyl_transf_3_dom.
DR   InterPro; IPR006621; Nose-resist-to-fluoxetine_N.
DR   PANTHER; PTHR11161:SF16; NRF DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR11161; O-ACYLTRANSFERASE; 1.
DR   Pfam; PF01757; Acyl_transf_3; 1.
DR   Pfam; PF20146; NRF; 1.
DR   SMART; SM00703; NRF; 1.
PE   4: Predicted;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           21..592
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5009306795"
FT   TRANSMEM        202..226
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        249..269
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        317..340
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        390..410
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        417..443
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        463..480
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        501..528
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          56..183
FT                   /note="Nose resistant-to-fluoxetine protein N-terminal"
FT                   /evidence="ECO:0000259|SMART:SM00703"
SQ   SEQUENCE   592 AA;  67320 MW;  9DCE5E5899389716 CRC64;
     MTRSLFSLFL LLTVCSEASA GWKDIFIPKP FKDLSPQCQN ETNIWIKSLE IFATISTECT
     IRKKCSIKEL QILEDNLYAV QQLDAFGQFP GSGVLELKTL YDGSNQECQR ISGKKYETNY
     CYLLLSPGKN VSCAITSSSP KYDYLPWRIA VCLPYSCNHT DMVEIFNQMS PYPFTACSAF
     CVALGDTLKP ALDFPNHLWN HLLLSAFVSV DTFFIMSGIV VAYLFFKMKP TRKTISNPMT
     WILFYVHRYL RLTPPMMLFI GFFTVYGPYI QGSFAASEFN QIFEETALCK TYWWHNLLYF
     NNFDTTTESS SKTCYNISWY LAVDTQLYLI APIILIAFFF SFSAGTTAVV TGCLGSIITT
     YILYSEYNLS ADGFGNGNGN DLNRIAYSKP WIRCPPYLVG LFTGYLLAVY GSRKIRLNWA
     LCICGWIAAF VIAGFCIFSS YDYDKGSKWS VFTRATYYNF DRLGWAFFIC WVVGANHMGW
     GGPINNFMSH PIWQPFGRLS YCAYIVHWMF LYVSIPATLL AYVFAFFWSC LFEIPTLKLE
     KMLIEALIGG GGRTSLKVGD AAPKINVEVK KNDEENKQIT ELENGKTESA KL
//